Top news

View all

27 April 2023

Immunisation partners outline ambitious plan to protect millions of girls in lower- and middle-income countries against cervical cancer

Over the next few years, Gavi, the Vaccine Alliance and partners will focus efforts to revitalise access to the human papillomavirus (HPV) vaccine to reach 86 million adolescent girls, rapidly recover and improve coverage, and help build…

26 April 2023

Funding disbursed to boost vaccine access in humanitarian and fragile settings

The funding will enable international and local civil society organisations to complement public health service efforts by accessing communities not reached by government services, such as in cross-border settings and conflict zones, across the…

25 April 2023

Gavi outlines plans to build sustainable supply of malaria vaccines

A new paper published today by Gavi outlines how the world can increase supply to meet demand within the next few years by growing the number of manufacturers and supporting scale-up through predictable demand.

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published monthly.

View all

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Mehr erfahren

 

 

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Mehr erfahren

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Mehr erfahren

Top VaccinesWork stories

View all stories

12 May 2023

Mpox is no longer officially a public health emergency; here’s why we shouldn’t let down our guard

While the global outbreak of mpox is easing, the disease continues to circulate and people in Africa and Latin America have few vaccines or treatments.

12 May 2023

Under Debate: The Origins of Mysterious Neurological Disease

Some health authorities say that nodding syndrome is likely caused by a parasite, but questions remain.

12 May 2023

From smallpox to COVID: the medical inventions that have seen off infectious diseases over the past century

Infectious diseases have shaped human history. Here are some of the medical innovations that have helped fight the most destructive ones since the 1920s.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Mehr erfahren

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Mehr erfahren

Our impact

Syringe >981 million children immunised
First aid locator >16.2 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >185.3 US$ billion in economic benefits for countries (2000–2021)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Mehr erfahren

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Mehr erfahren

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter